Bird R R, Hall B, Chapman D, Hobbs K E
Academic Department of Surgery, Royal Free Hospital School of Medicine, University of London, United Kingdom.
Thromb Res. 1988 Sep 1;51(5):471-83. doi: 10.1016/0049-3848(88)90113-2.
The use of phosphorylcholine (PC) containing compounds as possible biomaterials has been evaluated by material thrombelastography (MTEG). The detailed analysis of the MTEG technique is discussed. A remarkable reduction of thrombogenicity by compounds containing the PC group is demonstrated. The results observed with a polymerised PC-lipid indicate potential use of such substances as biomaterials with minimal thrombogenicity.
